Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT00091247
First received: September 7, 2004
Last updated: August 12, 2016
Last verified: August 2016